NIBE Share Price Jump 6% After Board Approves ₹250 Crore Fundraising Plan

NIBE share price (NSE: NIBE) gained strong momentum on Wednesday, December 24, after the company announced a major fundraising plan. The stock jumped up to 5.69% to an intraday high of ₹1,186.75 on the BSE. By 9:30 AM, shares were trading 3.34% higher at ₹1,160.30, while the Sensex remained largely flat.

Why Did Nibe Share Price Rise Today?

The rally came after NIBE informed stock exchanges that its board of directors approved a proposal to raise funds of up to ₹249.85 crore at a meeting held on December 23, 2025.

According to the company’s filing, the fundraising will be done through a mix of equity shares and warrants.

Details of The Fundraising Plan

NIBE plans to issue:

• Up to 4.40 lakh equity shares of face value ₹10 each at an issue price of ₹1,248 per share, including a premium of ₹1,238
• Up to 15.62 lakh equity warrants, each convertible into one equity share at the same issue price of ₹1,248 per warrant

This move is expected to strengthen the company’s financial position.

Recent Developments at NIBE

Earlier this month, NIBE received possession of a large industrial land parcel in the Shirdi Industrial Area, Maharashtra, from MIDC.

Meanwhile, the company’s CFO Rajesh Khatri resigned in November 2025 citing personal reasons.

NIBE Financial Performance 

In the September quarter of FY26, NIBE reported:

• A net loss of ₹9.68 crore, compared to a profit of ₹8.89 crore in Q2FY25
• Revenue fell to ₹73.36 crore, from ₹135.98 crore a year ago

Read More: Best Gold Mutual Funds in India for Dec 2025!

About NIBE

NIBE is an Indian defence technology company involved in the design, manufacturing, and integration of advanced defence systems. The company focuses on innovation, self-reliance, and exports in the defence sector.

NIBE has a market capitalisation of ₹1,677.94 crore and is part of the BSE SmallCap segment. Its 52-week high stands at ₹2,000.55, while the 52-week low is ₹753.05.

Conclusion

NIBE’s sharp stock movement reflects investor optimism around its ₹250 crore fundraise, despite recent financial losses. The capital infusion could support future expansion and strengthen its long-term defence manufacturing plans.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.